India, Oct. 16 -- Pharmaceutical-sector focussed AI startup Graph AI has secured $3 Mn (around INR 26.37 Cr) in its seed funding round led by Bessemer Venture Partners.

In a statement, the startup said it will use the funds for product innovation, team expansion, and fast-tracking market adoption for its proprietary pharmacovigilance automation platform.

Founded last year by Raghav Parvataraju (CEO), Vijay Ponukumati (CTO), Mohan Konyala (CPO), and Ashutosh Bordekar (CFO), Graph AI provides an AI-native platform 'Graph Safety', which automates adverse drug event (ADE) monitoring, regulatory submissions, and aggregates safety intelligence for the pharmaceutical and biotech industries.

Pharmacovigilance, which is mandated by global drug ...